MedTrace Logo

Retrospective Epidemiological Study on Botulism in Intensive Care Units in France

NCT03658902 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2018-09-06

No results posted yet for this study

Summary

Botulism poisoning is a rare but serious illness. Because of it's low incidence, it is not well known by physicians. Most studies describing botulism date back to the last century and do not take into account recent advances in intensive care.

The objective of this study is to describe the clinical course, interventions and outcomes of patients with severe botulism poisoning requiring a hospitalisation in an intensive care or high dependancy unit.

Conditions

  • Botulism; Poisoning

Sponsors & Collaborators

  • Centre Hospitalier le Mans

    lead OTHER

Principal Investigators

  • Christophe Guitton, MD · Centre Hospitalier le Mans

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2017-12-31
Completion
2018-08-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03658902 on ClinicalTrials.gov